BlaidsX Micro vs Resound Vivia 9 60S microRIE

The BlaidsX Micro is a budget-priced OTC hearing aid in the visible-in-ear style, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. At $499, it sits in the lowest price tier for the category but ranks #59 of 65 OTC hearing aids tested, placing it in the bottom 11% of the category. In our testing, the BlaidsX Micro delivered mixed results across performance metrics. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5 after tuning—0.46 points above the category average. Speech in quiet performance is slightly above average at 2.9/5, though this represents only mixed absolute quality. However, the device struggles significantly in several areas: speech in noise scores just 1.0/5, falling 0.48 points below average, while own-voice comfort is notably low at 1.0/5, which is 1.51 points below average. Music streaming is a significant weakness, scoring 0.0/5—nearly 2 points below the category average. This makes the BlaidsX Micro unsuitable for users who prioritize streaming audio quality. The device uses disposable batteries rather than rechargeable options. At its $499 price point, several competitors offer stronger overall performance. The Elehear Beyond and Cearvol Wave both deliver higher sound scores at lower prices. The BlaidsX Micro may appeal to budget-conscious consumers who prioritize feedback-free wear and basic speech clarity in quiet environments, but those seeking balanced performance across features—especially streaming or challenging listening situations—should consider alternatives.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.